Investing.com - GE HealthCare (NASDAQ: GEHC) reported third quarter EPS of $1.14, $0.09 better than the analyst estimate of $1.05. Revenue for the quarter came in at $4.86B versus the consensus estimate of $4.87B.
Guidance
GE HealthCare sees FY 2024 EPS of $4.25-$4.35 versus the analyst consensus of $4.25.
GE HealthCare's stock price closed at $85.27. It is up 2.19% in the last 3 months and up 28.09% in the last 12 months.
GE HealthCare saw 1 positive EPS revisions and 11 negative EPS revisions in the last 90 days. See GE HealthCare's stock price’s past reactions to earnings here.
According to InvestingPro, GE HealthCare's Financial Health score is "good performance".
Check out GE HealthCare's recent earnings performance, and GE HealthCare's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar